Added to YB: 2017-08-31
Pitch date: 2017-08-31
MYOK:US [bullish]
MyoKardia, Inc.
+429.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and sells targeted therapies for the treatment of serious cardiovascular diseases.
Market Cap
$12.0B
Pitch Price
$42.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-39.77
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
MYOKARDIA INC COM MYOK:US
A summary for this pitch has not been created yet.
Read full article (0 min)